Skip to content
AnalystLens

Flutter Entertainment 8-K Report, Executive Changes (Dec 11, 2025)

Reports
Leadership Changes·Regulation FD·Exhibits & Filings
Filing Date
Filed December 11, 2025
Period End
December 11, 2025
Security
FLUT
In the record · 2016–202610-K810-Q98-K280

FLUT filed 8 annual reports (10-K), 9 quarterly reports (10-Q) and 280 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’26Nov ’26

Summary

Summary of the 8-K filed December 11, 2025. Cited figures are marked; the original filing is the authoritative source.

Flutter Entertainment plc reported on December 11, 2025 that its Board of Directors has appointed Sally Susman as a non-executive director, effective at the conclusion of the Company's Annual General Meeting currently scheduled for May 29, 2026.

The Board has determined that Ms. Susman is independent under New York Stock Exchange listing standards, and she has not been appointed to any Board committee at this time. The filing states that she will receive compensation consistent with the Company's fee schedule for non-executive directors, as described in the 2025 proxy statement. Ms. Susman, age 64, is currently Executive Vice President and Chief Corporate Affairs Officer at Pfizer Inc., a role she intends to step down from at the conclusion of 2025.

She previously served as Chief Communications Officer of the Estée Lauder Companies Inc. and as Executive Vice President of Global Communications at American Express Company. She currently serves as a non-executive director of UL Solutions, Inc. and has served on the boards of Equity Office Properties Trust and WPP plc. The filing states there are no family relationships or arrangements under which she was elected, and that she is not party to any transaction requiring disclosure under Item 404(a) of Regulation S-K.

The announcement is furnished as Exhibit 99.1, an RNS Announcement released in London. According to that announcement, John Bryant, Chair of the Board, said the appointment is in line with the Board renewal program, having regard to the scale, geographic breadth and growth of the business.

Key Highlights

  1. Sally Susman appointed as a non-executive director, effective at the conclusion of the Annual General Meeting scheduled for May 29, 2026
  2. Board has determined Ms. Susman is independent under NYSE listing standards
  3. Ms. Susman has not been appointed to any Board committee at this time
  4. Ms. Susman is currently EVP and Chief Corporate Affairs Officer at Pfizer Inc. and intends to step down at the conclusion of 2025
  5. Prior roles include Chief Communications Officer at Estée Lauder Companies and EVP of Global Communications at American Express
  6. Current non-executive directorship at UL Solutions, Inc.; past roles at Equity Office Properties Trust and WPP plc
  7. Appointment described by the Chair as part of the Board renewal program, reflecting the scale, geographic breadth and growth of the business

Frequently Asked Questions

  1. When does the new director's appointment take effect?

    The appointment is effective as of the conclusion of the Company's Annual General Meeting, currently scheduled for May 29, 2026.

  2. Is the new director considered independent?

    Yes. The Board has determined that Ms. Susman is an independent director in accordance with New York Stock Exchange listing standards.

  3. How will the new director be compensated?

    She will receive compensation consistent with the Company's fee schedule for non-executive directors, which is described in the Company's definitive Proxy Statement for its 2025 Annual General Meeting filed on April 24, 2025.

  4. Will Ms. Susman serve on any Board committees?

    Not at this time. The filing states she has not been appointed as a member of any Board committee.

  5. Are there any related-party or family ties disclosed?

    The filing states Ms. Susman has no family relationships with any executive officer or director of the Company or its affiliates, there are no arrangements under which she was elected, and she is not party to any transaction requiring disclosure under Item 404(a) of Regulation S-K.